000			02012 a2200505 4500
005			20250517024125.0
264		0	_c20150603
008			201506s 0 0 eng d
022			_a1879-355X
024	7		_a10.1016/j.ijrobp.2014.12.050 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrachman, David G
245	0	0	_aPhase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. _h[electronic resource]
260			_bInternational journal of radiation oncology, biology, physics _cApr 2015
300			_a961-7 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAntineoplastic Agents, Alkylating _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBrain Neoplasms _xmortality
650	0	4	_aChemoradiotherapy _xadverse effects
650	0	4	_aDacarbazine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDose Fractionation, Radiation
650	0	4	_aFemale
650	0	4	_aGlioblastoma _xmortality
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMetalloporphyrins _xadministration & dosage
650	0	4	_aMultivariate Analysis
650	0	4	_aSupratentorial Neoplasms _xmortality
650	0	4	_aTemozolomide
700	1		_aPugh, Stephanie L
700	1		_aAshby, Lynn S
700	1		_aThomas, Theresa A
700	1		_aDunbar, Erin M
700	1		_aNarayan, Samir
700	1		_aRobins, H Ian
700	1		_aBovi, Joseph A
700	1		_aRockhill, Jason K
700	1		_aWon, Minhee
700	1		_aCurran, Walter P
773	0		_tInternational journal of radiation oncology, biology, physics _gvol. 91 _gno. 5 _gp. 961-7
856	4	0	_uhttps://doi.org/10.1016/j.ijrobp.2014.12.050 _zAvailable from publisher's website
999			_c24765124 _d24765124